+67.8%
CHYM vs IVZ
+30.5%
+37.3%
-41.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.9% | +4.2% | +1.7% | +3.1% |
| 7D | +3.7% | +2.6% | +1.1% | +1.9% |
| 30D | +5.6% | -3.5% | +9.1% | +8.0% |
| 3M | +19.7% | -7.4% | +27.1% | +25.7% |
| 6M | +35.3% | +14.7% | +20.6% | +17.9% |
| YTD | +18.7% | +14.6% | +4.1% | +2.6% |
| 1Y | +67.8% | +30.7% | +37.1% | +31.9% |
| All | +67.8% | +30.5% | +37.3% | +31.9% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling